+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

ß-NMN Supplements Market by Form (Capsules, Liquid, Powder), Distribution Channel (Direct Sales, Online Retail, Retail Pharmacies), End User, Application, Dosage Range, Price Tier - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 187 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6128323
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

In the past decade, the emergence of nicotinamide mononucleotide supplements has reshaped the nutraceutical landscape. Among these, β-NMN has drawn particular attention due to its role as a key NAD+ precursor integral to cellular metabolism and energy production. As researchers have elucidated the molecular mechanisms that underlie aging, interest in β-NMN supplementation has surged, driven by its potential to support longevity, cognitive function, and metabolic health. Furthermore, ongoing clinical trials have provided initial evidence of improved blood flow and mitochondrial efficiency, reinforcing its reputation as a cornerstone of modern wellness strategies.

Moreover, strategic collaborations between academic institutions and private laboratories have accelerated innovation cycles, enabling rapid formulation improvements that address stability and bioavailability challenges. Simultaneously, investment flows into downstream manufacturing and encapsulation technologies have lowered barriers for new entrants, creating a dynamic environment that balances scientific rigor with commercial agility.

Transitioning from foundational biology to market realities, it becomes evident that the β-NMN sector sits at a crossroads of opportunity and complexity. Stakeholders must navigate varying regulatory landscapes, manage supply chain intricacies for raw material procurement, and anticipate the impact of evolving consumer expectations regarding transparency and sustainability. This introductory overview lays the groundwork for an in-depth exploration of the forces shaping this rapidly evolving industry.

Evolutionary Transformations in β-NMN Supplementation That Signal Shifts in Consumer Preferences and Technological Advances Across the Value Chain

Over recent years, the β-NMN supplement landscape has undergone profound transformations driven by shifting consumer demands and technological breakthroughs. The initial wave of product launches prioritized basic formulations, but today’s consumers expect enhanced bioavailability, leading manufacturers to invest in microencapsulation, liposomal delivery systems, and proprietary plant-based carriers. In response, formulation scientists have collaborated with technology partners to develop next-generation delivery platforms that ensure controlled release and improved absorption.

At the same time, distribution channels have evolved beyond traditional retail. Digital marketplaces and brand-owned e-commerce platforms have emerged as primary drivers of both awareness and sales. This shift has enabled direct engagement with end users, who now seek educational content, subscription models, and personalized dosage recommendations. Consequently, companies are leveraging data analytics and AI to tailor marketing approaches and refine consumer profiling.

Moreover, sustainability considerations have entered the strategic agenda. Suppliers are adopting traceable sourcing practices for raw materials and investing in eco-friendly packaging solutions to meet the expectations of environmentally conscious consumers. Simultaneously, research partnerships between biotech firms and academic laboratories have accelerated the validation of novel applications, including cognitive resilience and metabolic support, thereby expanding the traditional anti-aging paradigm.

Furthermore, regulatory environments are adapting to accommodate rapid product innovation without compromising safety. Regulatory authorities are refining guidelines around clinical substantiation and label claims, prompting firms to enhance their quality assurance and compliance frameworks. This regulatory evolution, in turn, bolsters consumer confidence and fosters a more transparent marketplace for β-NMN supplements.

Assessing the Comprehensive Effects of Recent United States Tariffs on β-NMN Supplements and Their Implications for Strategic Supply Chain Resilience

As of 2025, the introduction of enhanced United States tariffs on key precursor materials has exerted a significant influence on the economics of β-NMN production. These measures, designed to protect domestic manufacturing interests, have increased the cost of imported bioactive ingredients, compelling supplement producers to reassess their sourcing strategies and price structures. Consequently, raw material costs have risen, exerting pressure on profit margins and prompting companies to explore alternative supply channels.

In parallel, supply chain disruptions triggered by tariff-related uncertainties have underscored the importance of resilience planning. Many manufacturers have pursued nearshoring partnerships to secure consistent access to critical inputs, while others have diversified their supplier base across multiple geographies to mitigate dependency risks. This diversification has not only reduced vulnerability to trade policy fluctuations but also opened opportunities for collaborative innovation with emerging producers offering competitive pricing.

Furthermore, the passing of these tariffs has accelerated conversations around vertical integration, with certain players investing in in-house extraction capabilities to bypass volatility in third-party markets. Although this approach requires substantial capital investment, it has yielded long-term cost efficiencies and stronger control over quality assurance. Simultaneously, some brands have elected to absorb a portion of the increased costs to preserve retail price stability, thereby reinforcing customer loyalty and minimizing market friction.

Ultimately, the cumulative impact of the 2025 tariff adjustments has driven a strategic shift toward agile procurement models and enhanced supply chain agility, underscoring the dynamic interplay between trade policy and nutritional supplement innovation.

Decoding Critical Segmentation Patterns in β-NMN Supplements to Uncover Targeted Product Formulations and Tailored Market Approaches

In examining the β-NMN supplement landscape through the lens of product formats, it becomes clear that capsules continue to dominate preference among consumers seeking simplicity and shelf stability, though liquids are gaining traction for those prioritizing rapid absorption and customizable dosing. Meanwhile, powdered forms are favored by wellness aficionados who integrate supplements into smoothies and functional beverages, and tablets appeal to cost-conscious buyers looking for compact, easy-to-dose options. Transitioning from format preferences to distribution dynamics, direct sales models have enabled brands to cultivate one-on-one relationships with customers, while digital storefronts on brand websites, online marketplaces, and third-party platforms have expanded accessibility and enhanced subscription opportunities. Retail pharmacies, both chain and independent, remain pivotal for consumers seeking professional guidance at the point of purchase, and specialty stores contribute experiential value by offering personalized consultations and branded promotions.

Turning to user demographics, the athlete community has embraced β-NMN formulations to support recovery and performance, while beauty enthusiasts prioritize skin health benefits rooted in cellular rejuvenation. The elderly segment views these supplements as a tool for maintaining vitality and neuroprotection, and the general population perceives them as an all-purpose wellness solution. Against this backdrop, application-driven choices are emerging; products positioned for anti-aging resonate with mature consumers, cardiovascular formulations target heart health awareness, energy metabolism blends attract daytime nutrition seekers, and neuroprotection variants appeal to those focused on cognitive longevity.

In addressing dosage preferences, moderate ranges between 125 and 500 milligrams reflect a balance between efficacy and consumer comfort, with higher dosage offerings catering to advanced users and lower strength options serving as entry points. Price tier segmentation delineates economy offerings for budget-conscious buyers, mid market variants that combine quality and value, and premium ranges that command higher price premiums through clinical substantiation and luxury positioning. Together, these segmentation insights map the multifaceted decision drivers shaping β-NMN supplement strategies today.

Regional Dynamics Shaping the Adoption and Growth of β-NMN Supplements Across the Americas, Europe Middle East and Africa, and Asia Pacific Markets

In the Americas, robust consumer interest in cellular health and longevity has driven widespread adoption of β-NMN supplements, with North American markets leading in both online subscriptions and specialty retail engagements. Regulatory frameworks in the region have matured to accommodate clear labeling requirements, fostering a climate of trust that underpins brand loyalty. Meanwhile, supply chain networks in Latin America are evolving to support local distribution, and strategic partnerships are emerging to streamline cold chain logistics and premium product launches.

Across Europe, Middle East, and Africa, heterogeneous market conditions have given rise to varied adoption rates and regulatory landscapes. In Western Europe, stringent health authorities emphasize clinical backing and safety dossiers, prompting brands to prioritize substantiated claims and rigorous quality control. Gulf Cooperation Council countries exhibit growing interest driven by aging demographic trends, with urban centers increasingly hosting high-end wellness salons and pharmacies that cater to affluent consumers. In contrast, select African markets are still in nascent stages of nutraceutical maturation, creating potential for early movers to establish brand recognition and educational outreach.

Meanwhile, Asia-Pacific has emerged as a dynamic arena for β-NMN innovation, fueled by a combination of traditional wellness philosophies and cutting-edge biotech investments. East Asian markets demonstrate high receptivity to premium formulations, while South Asian consumers exhibit cautious optimism, gravitating toward mid market pricing supported by local trust signals. Southeast Asian distribution networks leverage e-commerce platforms and social commerce to penetrate urban and peri-urban regions alike. Across the entire region, a growing emphasis on clean label ingredients and sustainable practices enhances the appeal of formulations that marry modern science with heritage herbal frameworks.

Leading Industry Players Driving Innovation and Competitive Strategies in the β-NMN Supplement Sector Through Strategic Partnerships and Research Initiatives

Prominent industry participants have distinguished themselves through strategic alliances, proprietary technology platforms, and aggressive research and development initiatives. Leading manufacturers have formed partnerships with biotech startups to gain early access to novel enzymatic processes that optimize β-NMN yield and purity. Concurrently, some brands have pursued collaborations with contract research organizations to support advanced clinical studies, thereby reinforcing product credibility and differentiating themselves in a crowded marketplace.

In addition, major players have implemented robust quality management systems that adhere to international standards, enabling smoother entry into regulated markets and fostering trust among healthcare practitioners. These companies frequently leverage digital health tools to monitor post-market performance and collect real-world data, which informs iterative product enhancements and marketing narratives. Similarly, certain forward-thinking firms have integrated blockchain-based traceability solutions to offer end-to-end visibility of raw material sourcing and manufacturing processes, responding to consumer demands for transparency.

More recently, mergers and acquisitions have reshaped the competitive landscape, allowing established supplement producers to absorb specialized biotech targets with complementary capabilities. This consolidation trend not only amplifies economies of scale but also accelerates time to market for differentiated products such as sustained release capsules and enhanced solubility powders. Moreover, a growing number of mid-sized companies are carving niche positions by offering targeted formulations that address specific applications such as cardiovascular support or neuroprotection. These agile innovators often leverage social media communities and thought leadership content to build dedicated followings, illustrating how differentiated branding can complement scale-driven advantages. Across all competitive strategies, the common thread remains an uncompromising focus on science-based validation, supply chain resilience, and direct consumer engagement through personalized digital ecosystems.

Actionable Strategic Recommendations for Industry Executives to Capitalize on Emerging β-NMN Supplement Trends and Strengthen Market Positioning

In the current competitive environment, companies seeking to strengthen their market position should prioritize transparent communication of scientific evidence and leverage third-party validation to build credibility. By publishing peer-reviewed study data and partnering with respected thought leaders, brands can address consumer skepticism and establish authority in the NAD+ supplement space. Additionally, investment in scalable manufacturing processes will enable rapid response to demand fluctuations while ensuring consistent product quality across formats.

Furthermore, diversification of distribution strategies is essential. Expanding direct-to-consumer channels through proprietary e-commerce platforms can deepen customer relationships and facilitate personalized offerings. At the same time, cultivating strategic alliances with retail pharmacies and specialty health stores will provide additional touchpoints for consumer education and sampling programs. Simultaneously, regional expansion efforts should be underpinned by localized marketing campaigns that resonate with cultural nuances and regulatory requirements.

Moreover, companies must integrate sustainability practices into their core operations, from ethically sourced raw materials to recyclable packaging solutions. Not only does this approach align with consumer values, but it also prepares businesses for evolving environmental regulations. In parallel, adopting advanced analytic tools to segment audiences based on usage patterns and health aspirations will drive more effective targeting and higher retention rates.

By executing these strategic recommendations, industry leaders can harness emerging trends, mitigate supply chain risks, and capture new growth opportunities. In doing so, they will fortify their competitive positioning and deliver meaningful value to end users across diverse market segments.

Rigorous Research Methodology Combining Primary and Secondary Data Insights to Deliver a Comprehensive Analysis of the β-NMN Supplement Market

This research employs a rigorous methodology designed to ensure comprehensive and reliable insights into the β-NMN supplement sector. Primary data collection involved in-depth interviews with C-suite executives, product development experts, and distribution channel specialists to capture firsthand perspectives on emerging trends and operational challenges. Concurrently, consumer insights were gathered through structured surveys that assessed preferences related to formulation, dosage, and purchasing behaviors.

In parallel, extensive secondary research was conducted to gather contextual information from scientific publications, regulatory filings, patent databases, and industry white papers. This dual approach enabled triangulation of qualitative and quantitative findings, ensuring that observations rooted in expert opinion were corroborated by empirical evidence. Furthermore, a detailed evaluation of supply chain footprints and tariff impacts was performed using trade data analytics and customs reporting tools to quantify cost drivers and logistical constraints.

Additionally, iterative workshops with internal analysts were held to validate key assumptions and refine segmentation frameworks, encompassing product formats, distribution channels, end user profiles, application categories, dosage ranges, and price tiers. This collaborative process ensured that the final segmentation model accurately reflects the multifaceted decision drivers shaping market dynamics. Finally, the aggregated data underwent rigorous quality control checks, including cross validation and outlier analysis, to eliminate inconsistencies and reinforce the robustness of the conclusions. Through this comprehensive methodology, the study delivers a solid foundation for strategic decision making and long-term planning in the β-NMN supplement space.

Conclusive Perspectives on the β-NMN Supplement Sector Synthesizing Key Findings and Highlighting Future Outlook Opportunities for Stakeholders

As the β-NMN supplement landscape continues to evolve, stakeholders face a confluence of scientific advancements, regulatory adjustments, and shifting consumer expectations. The insights outlined throughout this summary underscore the critical importance of robust supply chain strategies, evidence-backed formulation development, and dynamic distribution approaches. Companies that effectively integrate these elements are positioned to capitalize on the expanding appetite for NAD+ precursors and related wellness applications.

Looking ahead, the intersection of personalized nutrition and digital health will further redefine value propositions, with data-driven supplementation plans and telehealth integrations becoming increasingly commonplace. Moreover, as regulatory bodies worldwide harmonize guidelines for nutraceutical claims, transparent communication of clinical validation will emerge as a key competitive differentiator. Simultaneously, sustainability and ethical sourcing will remain integral to brand reputations, demanding continued innovation in packaging, logistics, and raw material procurement.

In summary, the β-NMN supplement sector stands at a strategic inflection point. By embracing science-led innovation, adaptive distribution models, and consumer-centric engagement strategies, industry participants can navigate the complexities of trade policy impacts and regional market diversity. Ultimately, sustained success will hinge on the ability to anticipate emerging trends, maintain operational agility, and deliver compelling, evidence-based solutions that resonate with health-conscious audiences worldwide.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Form
    • Capsules
    • Liquid
    • Powder
    • Tablets
  • Distribution Channel
    • Direct Sales
    • Online Retail
      • Brand Website
      • Marketplaces
      • Third Party Platforms
    • Retail Pharmacies
      • Chain Pharmacies
      • Independent Pharmacies
    • Specialty Stores
  • End User
    • Athletes
    • Beauty Enthusiasts
    • Elderly
    • General Population
  • Application
    • Anti Aging
    • Cardiovascular Health
    • Energy Metabolism
    • Neuroprotection
  • Dosage Range
    • 125-250 Mg
    • 250-500 Mg
    • Above 500 Mg
    • Below 125 Mg
  • Price Tier
    • Economy
    • Mid Market
    • Premium
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • ChromaDex Corporation
  • Elysium Health, Inc.
  • ProHealth Longevity, LLC
  • Alive By Nature, Inc.
  • GeneHarbour Group Co., Ltd.
  • Pure Encapsulations, LLC
  • HPN Nutraceuticals, LLC
  • Life Extension Foundation, Inc.
  • Swanson Health Products
  • Zhou Nutrition LLC

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Emerging liposomal and sublingual delivery systems enhancing ß-NMN bioavailability in aging interventions
5.2. Integration of ß-NMN supplements with personalized genomics for tailored NAD+ optimization regimens
5.3. Regulatory progress and GRAS approvals shaping ß-NMN supplement market expansion in North America
5.4. Development of sustainable fermentation-based production methods reducing ß-NMN supplement costs and carbon footprint
5.5. Synergistic ß-NMN formulations combining resveratrol and pterostilbene for enhanced longevity benefits
5.6. Surging direct-to-consumer subscription platforms driving ß-NMN adoption through digital health ecosystems
5.7. Topical and cosmetic ß-NMN-infused skincare products targeting cellular NAD+ replenishment and anti-aging effects
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. ß-NMN Supplements Market, by Form
8.1. Introduction
8.2. Capsules
8.3. Liquid
8.4. Powder
8.5. Tablets
9. ß-NMN Supplements Market, by Distribution Channel
9.1. Introduction
9.2. Direct Sales
9.3. Online Retail
9.3.1. Brand Website
9.3.2. Marketplaces
9.3.3. Third Party Platforms
9.4. Retail Pharmacies
9.4.1. Chain Pharmacies
9.4.2. Independent Pharmacies
9.5. Specialty Stores
10. ß-NMN Supplements Market, by End User
10.1. Introduction
10.2. Athletes
10.3. Beauty Enthusiasts
10.4. Elderly
10.5. General Population
11. ß-NMN Supplements Market, by Application
11.1. Introduction
11.2. Anti Aging
11.3. Cardiovascular Health
11.4. Energy Metabolism
11.5. Neuroprotection
12. ß-NMN Supplements Market, by Dosage Range
12.1. Introduction
12.2. 125-250 Mg
12.3. 250-500 Mg
12.4. Above 500 Mg
12.5. Below 125 Mg
13. ß-NMN Supplements Market, by Price Tier
13.1. Introduction
13.2. Economy
13.3. Mid Market
13.4. Premium
14. Americas ß-NMN Supplements Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa ß-NMN Supplements Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific ß-NMN Supplements Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. ChromaDex Corporation
17.3.2. Elysium Health, Inc.
17.3.3. ProHealth Longevity, LLC
17.3.4. Alive by Nature, Inc.
17.3.5. GeneHarbour Group Co., Ltd.
17.3.6. Pure Encapsulations, LLC
17.3.7. HPN Nutraceuticals, LLC
17.3.8. Life Extension Foundation, Inc.
17.3.9. Swanson Health Products
17.3.10. Zhou Nutrition LLC
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. ?-NMN SUPPLEMENTS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY FORM, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY DOSAGE RANGE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY DOSAGE RANGE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY PRICE TIER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY PRICE TIER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS ?-NMN SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS ?-NMN SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES ?-NMN SUPPLEMENTS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES ?-NMN SUPPLEMENTS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ?-NMN SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ?-NMN SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC ?-NMN SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC ?-NMN SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ?-NMN SUPPLEMENTS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. ?-NMN SUPPLEMENTS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. ?-NMN SUPPLEMENTS MARKET: RESEARCHAI
FIGURE 28. ?-NMN SUPPLEMENTS MARKET: RESEARCHSTATISTICS
FIGURE 29. ?-NMN SUPPLEMENTS MARKET: RESEARCHCONTACTS
FIGURE 30. ?-NMN SUPPLEMENTS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ?-NMN SUPPLEMENTS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY CAPSULES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY CAPSULES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY LIQUID, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY LIQUID, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY POWDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY POWDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY TABLETS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY TABLETS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY BRAND WEBSITE, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY BRAND WEBSITE, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY MARKETPLACES, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY MARKETPLACES, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY THIRD PARTY PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY THIRD PARTY PLATFORMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY SPECIALTY STORES, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY SPECIALTY STORES, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY ATHLETES, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY ATHLETES, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY BEAUTY ENTHUSIASTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY BEAUTY ENTHUSIASTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY ELDERLY, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY ELDERLY, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY GENERAL POPULATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY GENERAL POPULATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY ANTI AGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY ANTI AGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY CARDIOVASCULAR HEALTH, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY CARDIOVASCULAR HEALTH, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY ENERGY METABOLISM, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY ENERGY METABOLISM, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY NEUROPROTECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY NEUROPROTECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY DOSAGE RANGE, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY DOSAGE RANGE, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY 125-250 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY 125-250 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY 250-500 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY 250-500 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY ABOVE 500 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY ABOVE 500 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY BELOW 125 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY BELOW 125 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY PRICE TIER, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY PRICE TIER, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY ECONOMY, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY ECONOMY, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY MID MARKET, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY MID MARKET, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY PREMIUM, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL ?-NMN SUPPLEMENTS MARKET SIZE, BY PREMIUM, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS ?-NMN SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS ?-NMN SUPPLEMENTS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS ?-NMN SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS ?-NMN SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS ?-NMN SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS ?-NMN SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS ?-NMN SUPPLEMENTS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS ?-NMN SUPPLEMENTS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS ?-NMN SUPPLEMENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS ?-NMN SUPPLEMENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS ?-NMN SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS ?-NMN SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS ?-NMN SUPPLEMENTS MARKET SIZE, BY DOSAGE RANGE, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS ?-NMN SUPPLEMENTS MARKET SIZE, BY DOSAGE RANGE, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS ?-NMN SUPPLEMENTS MARKET SIZE, BY PRICE TIER, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS ?-NMN SUPPLEMENTS MARKET SIZE, BY PRICE TIER, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS ?-NMN SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS ?-NMN SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES ?-NMN SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES ?-NMN SUPPLEMENTS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES ?-NMN SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES ?-NMN SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES ?-NMN SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES ?-NMN SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES ?-NMN SUPPLEMENTS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES ?-NMN SUPPLEMENTS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES ?-NMN SUPPLEMENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES ?-NMN SUPPLEMENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES ?-NMN SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES ?-NMN SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES ?-NMN SUPPLEMENTS MARKET SIZE, BY DOSAGE RANGE, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES ?-NMN SUPPLEMENTS MARKET SIZE, BY DOSAGE RANGE, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES ?-NMN SUPPLEMENTS MARKET SIZE, BY PRICE TIER, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES ?-NMN SUPPLEMENTS MARKET SIZE, BY PRICE TIER, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES ?-NMN SUPPLEMENTS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES ?-NMN SUPPLEMENTS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 117. CANADA ?-NMN SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 118. CANADA ?-NMN SUPPLEMENTS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 119. CANADA ?-NMN SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 120. CANADA ?-NMN SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 121. CANADA ?-NMN SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 122. CANADA ?-NMN SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 123. CANADA ?-NMN SUPPLEMENTS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 124. CANADA ?-NMN SUPPLEMENTS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 125. CANADA ?-NMN SUPPLEMENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 126. CANADA ?-NMN SUPPLEMENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 127. CANADA ?-NMN SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 128. CANADA ?-NMN SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 129. CANADA ?-NMN SUPPLEMENTS MARKET SIZE, BY DOSAGE RANGE, 2018-2024 (USD MILLION)
TABLE 130. CANADA ?-NMN SUPPLEMENTS MARKET SIZE, BY DOSAGE RANGE, 2025-2030 (USD MILLION)
TABLE 131. CANADA ?-NMN SUPPLEMENTS MARKET SIZE, BY PRICE TIER, 2018-2024 (USD MILLION)
TABLE 132. CANADA ?-NMN SUPPLEMENTS MARKET SIZE, BY PRICE TIER, 2025-2030 (USD MILLION)
TABLE 133. MEXICO ?-NMN SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 134. MEXICO ?-NMN SUPPLEMENTS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 135. MEXICO ?-NMN SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 136. MEXICO ?-NMN SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 137. MEXICO ?-NMN SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 138. MEXICO ?-NMN SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 139. MEXICO ?-NMN SUPPLEMENTS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 140. MEXICO ?-NMN SUPPLEMENTS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 141. MEXICO ?-NMN SUPPLEMENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 142. MEXICO ?-NMN SUPPLEMENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 143. MEXICO ?-NMN SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 144. MEXICO ?-NMN SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 145. MEXICO ?-NMN SUPPLEMENTS MARKET SIZE, BY DOSAGE RANGE, 2018-2024 (USD MILLION)
TABLE 146. MEXICO ?-NMN SUPPLEMENTS MARKET SIZE, BY DOSAGE RANGE, 2025-2030 (USD MILLION)
TABLE 147. MEXICO ?-NMN SUPPLEMENTS MARKET SIZE, BY PRICE TIER, 2018-2024 (USD MILLION)
TABLE 148. MEXICO ?-NMN SUPPLEMENTS MARKET SIZE, BY PRICE TIER, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL ?-NMN SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL ?-NMN SUPPLEMENTS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL ?-NMN SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL ?-NMN SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL ?-NMN SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL ?-NMN SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL ?-NMN SUPPLEMENTS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL ?-NMN SUPPLEMENTS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 157. BRAZIL ?-NMN SUPPLEMENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL ?-NMN SUPPLEMENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 159. BRAZIL ?-NMN SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 160. BRAZIL ?-NMN SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 161. BRAZIL ?-NMN SUPPLEMENTS MARKET SIZE, BY DOSAGE RANGE, 2018-2024 (USD MILLION)
TABLE 162. BRAZIL ?-NMN SUPPLEMENTS MARKET SIZE, BY DOSAGE RANGE, 2025-2030 (USD MILLION)
TABLE 163. BRAZIL ?-NMN SUPPLEMENTS MARKET SIZE, BY PRICE TIER, 2018-2024 (USD MILLION)
TABLE 164. BRAZIL ?-NMN SUPPLEMENTS MARKET SIZE, BY PRICE TIER, 2025-2030 (USD MILLION)
TABLE 165. ARGENTINA ?-NMN SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 166. ARGENTINA ?-NMN SUPPLEMENTS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 167. ARGENTINA ?-NMN SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 168. ARGENTINA ?-NMN SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 169. ARGENTINA ?-NMN SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 170. ARGENTINA ?-NMN SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 171. ARGENTINA ?-NMN SUPPLEMENTS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 172. ARGENTINA ?-NMN SUPPLEMENTS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 173. ARGENTINA ?-NMN SUPPLEMENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 174. ARGENTINA ?-NMN SUPPLEMENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 175. ARGENTINA ?-NMN SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 176. ARGENTINA ?-NMN SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 177. ARGENTINA ?-NMN SUPPLEMENTS MARKET SIZE, BY DOSAGE RANGE, 2018-2024 (USD MILLION)
TABLE 178. ARGENTINA ?-NMN SUPPLEMENTS MARKET SIZE, BY DOSAGE RANGE, 2025-2030 (USD MILLION)
TABLE 179. ARGENTINA ?-NMN SUPPLEMENTS MARKET SIZE, BY PRICE TIER, 2018-2024 (USD MILLION)
TABLE 180. ARGENTINA ?-NMN SUPPLEMENTS MARKET SIZE, BY PRICE TIER, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA ?-NMN SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA ?-NMN SUPPLEMENTS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA ?-NMN SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA ?-NMN SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA ?-NMN SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA ?-NMN SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA ?-NMN SUPPLEMENTS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA ?-NMN SUPPLEMENTS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA ?-NMN SUPPLEMENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA ?-NMN SUPPLEMENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA ?-NMN SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA ?-NMN SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA ?-NMN SUPPLEMENTS MARKET SIZE, BY DOSAGE RANGE, 2018-2024 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA ?-NMN SUPPLEMENTS MARKET SIZE, BY DOSAGE RANGE, 2025-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA ?-NMN SUPPLEMENTS MARKET SIZE, BY PRICE TIER, 2018-2024 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA ?-NMN SUPPLEMENTS MARKET SIZE, BY PRICE TIER, 2025-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA ?-NMN SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA ?-NMN SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM ?-NMN SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 200. UNITED KINGDOM ?-NMN SUPPLEMENTS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM ?-NMN SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 202. UNITED KINGDOM ?-NMN SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM ?-NMN SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 204. UNITED KINGDOM ?-NMN SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM ?-NMN SUPPLEMENTS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 206. UNITED KINGDOM ?-NMN SUPPLEMENTS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM ?-NMN SUPPLEMENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 208. UNITED KINGDOM ?-NMN SUPPLEMENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM ?-NMN SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 210. UNITED KINGDOM ?-NMN SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM ?-NMN SUPPLEMENTS MARKET SIZE, BY DOSAGE RANGE, 2018-2024 (USD MILLION)
TABLE 212. UNITED KINGDOM ?-NMN SUPPLEMENTS MARKET SIZE, BY DOSAGE RANGE, 2025-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM ?-NMN SUPPLEMENTS MARKET SIZE, BY PRICE TIER, 2018-2024 (USD MILLION)
TABLE 214. UNITED KINGDOM ?-NMN SUPPLEMENTS MARKET SIZE, BY PRICE TIER, 2025-2030 (USD MILLION)
TABLE 215. GERMANY ?-NMN SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 216. GERMANY ?-NMN SUPPLEMENTS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 217. GERMANY ?-NMN SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 218. GERMANY ?-NMN SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 219. GERMANY ?-NMN SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 220. GERMANY ?-NMN SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 221. GERMANY ?-NMN SUPPLEMENTS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 222. GERMANY ?-NMN SUPPLEMENTS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 223. GERMANY ?-NMN SUPPLEMENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 224. GERMANY ?-NMN SUPPLEMENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 225. GERMANY ?-NMN SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 226. GERMANY ?-NMN SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 227. GERMANY ?-NMN SUPPLEMENTS MARKET SIZE, BY DOSAGE RANGE, 2018-2024 (USD MILLION)
TABLE 228. GERMANY ?-NMN SUPPLEMENTS MARKET SIZE, BY DOSAGE RANGE, 2025-2030 (USD MILLION)
TABLE 229. GERMANY ?-NMN SUPPLEMENTS MARKET SIZE, BY PRICE TIER, 2018-2024 (USD MILLION)
TABLE 230. GERMANY ?-NMN SUPPLEMENTS MARKET SIZE, BY PRICE TIER, 2025-2030 (USD MILLION)
TABLE 231. FRANCE ?-NMN SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 232. FRANCE ?-NMN SUPPLEMENTS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 233. FRANCE ?-NMN SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 234. FRANCE ?-NMN SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 235. FRANCE ?-NMN SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 236. FRANCE ?-NMN SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 237. FRANCE ?-NMN SUPPLEMENTS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 238. FRANCE ?-NMN SUPPLEMENTS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 239. FRANCE ?-NMN SUPPLEMENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 240. FRANCE ?-NMN SUPPLEMENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 241. FRANCE ?-NMN SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 242. FRANCE ?-NMN SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 243. FRANCE ?-NMN SUPPLEMENTS MARKET SIZE, BY DOSAGE RANGE, 2018-2024 (USD MILLION)
TABLE 244. FRANCE ?-NMN SUPPLEMENTS MARKET SIZE, BY DOSAGE RANGE, 2025-2030 (USD MILLION)
TABLE 245. FRANCE ?-NMN SUPPLEMENTS MARKET SIZE, BY PRICE TIER, 2018-2024 (USD MILLION)
TABLE 246. FRANCE ?-NMN SUPPLEMENTS MARKET SIZE, BY PRICE TIER, 2025-2030 (USD MILLION)
TABLE 247. RUSSIA ?-NMN SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 248. RUSSIA ?-NMN SUPPLEMENTS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 249. RUSSIA ?-NMN SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 250. RUSSIA ?-NMN SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 251. RUSSIA ?-NMN SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 252. RUSSIA ?-NMN SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 253. RUSSIA ?-NMN SUPPLEMENTS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 254. RUSSIA ?-NMN SUPPLEMENTS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 255. RUSSIA ?-NMN SUPPLEMENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 256. RUSSIA ?-NMN SUPPLEMENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 257. RUSSIA ?-NMN SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 258. RUSSIA ?-NMN SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 259. RUSSIA ?-NMN SUPPLEMENTS MARKET SIZE, BY DOSAGE RANGE, 2018-2024 (USD MILLION)
TABLE 260. RUSSIA ?-NMN SUPPLEMENTS MARKET SIZE, BY DOSAGE RANGE, 2025-2030 (USD MILLION)
TABLE 261. RUSSIA ?-NMN SUPPLEMENTS MARKET SIZE, BY PRICE TIER, 2018-2024 (USD MILLION)
TABLE 262. RUSSIA ?-NMN SUPPLEMENTS MARKET SIZE, BY PRICE TIER, 2025-2030 (USD MILLION)
TABLE 263. ITALY ?-NMN SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 264. ITALY ?-NMN SUPPLEMENTS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 265. ITALY ?-NMN SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 266. ITALY ?-NMN SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 267. ITALY ?-NMN SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 268. ITALY ?-NMN SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 269. ITALY ?-NMN SUPPLEMENTS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 270. ITALY ?-NMN SUPPLEMENTS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 271. ITALY ?-NMN SUPPLEMENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 272. ITALY ?-NMN SUPPLEMENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 273. ITALY ?-NMN SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 274. ITALY ?-NMN SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 275. ITALY ?-NMN SUPPLEMENTS MARKET SIZE, BY DOSAGE RANGE, 2018-2024 (USD MILLION)
TABLE 276. ITALY ?-NMN SUPPLEMENTS MARKET SIZE, BY DOSAGE RANGE, 2025-2030 (USD MILLION)
TABLE 277. ITALY ?-NMN SUPPLEMENTS MARKET SIZE, BY PRICE TIER, 2018-2024 (USD MILLION)
TABLE 278. ITALY ?-NMN SUPPLEMENTS MARKET SIZE, BY PRICE TIER, 2025-2030 (USD MILLION)
TABLE 279. SPAIN ?-NMN SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 280. SPAIN ?-NMN SUPPLEMENTS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 281. SPAIN ?-NMN SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 282. SPAIN ?-NMN SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 283. SPAIN ?-NMN SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 284. SPAIN ?-NMN SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 285. SPAIN ?-NMN SUPPLEMENTS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 286. SPAIN ?-NMN SUPPLEMENTS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 287. SPAIN ?-NMN SUPPLEMENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 288. SPAIN ?-NMN SUPPLEMENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 289. SPAIN ?-NMN SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 290. SPAIN ?-NMN SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 291. SPAIN ?-NMN SUPPLEMENTS MARKET SIZE, BY DOSAGE RANGE, 2018-2024 (USD MILLION)
TABLE 292. SPAIN ?-NMN SUPPLEMENTS MARKET SIZE, BY DOSAGE RANGE, 2025-2030 (USD MILLION)
TABLE 293. SPAIN ?-NMN SUPPLEMENTS MARKET SIZE, BY PRICE TIER, 2018-2024 (USD MILLION)
TABLE 294. SPAIN ?-NMN SUPPLEMENTS MARKET SIZE, BY PRICE TIER, 2025-2030 (USD MILLION)
TABLE 295. UNITED ARAB EMIRATES ?-NMN SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 296. UNITED ARAB EMIRATES ?-NMN SUPPLEMENTS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 297. UNITED ARAB EMIRATES ?-NMN SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 298. UNITED ARAB EMIRATES ?-NMN SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 299. UNITED ARAB EMIRATES ?-NMN SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 300. UNITED ARAB EMIRATES ?-NMN SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 301. UNITED ARAB EMIRATES ?-NMN SUPPLEMENTS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 302. UNITED ARAB EMIRATES ?-NMN SUPPLEMENTS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 303. UNITED ARAB EMIRATES ?-NMN SUPPLEMENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 304. UNITED ARAB EMIRATES ?-NMN SUPPLEMENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 305. UNITED ARAB EMIRATES ?-NMN SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 306. UNITED ARAB EMIRATES ?-NMN SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 307. UNITED ARAB EMIRATES ?-NMN SUPPLEMENTS MARKET SIZE, BY DOSAGE RANGE, 2018-2024 (USD MILLION)
TABLE 308. UNITED ARAB EMIRATES ?-NMN SUPPLEMENTS MARKET SIZE, BY DOSAGE RANGE, 2025-2030 (USD MILLION)
TABLE 309. UNITED ARAB EMIRATES ?-NMN SUPPLEMENTS MARKET SIZE, BY PRICE TIER, 2018-2024 (USD MILLION)
TABLE 310. UNITED ARAB EMIRATES ?-NMN SUPPLEMENTS MARKET SIZE, BY PRICE TIER, 2025-2030 (USD MILLION)
TABLE 311. SAUDI ARABIA ?-NMN SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 312. SAUDI ARABIA ?-NMN SUPPLEMENTS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 313. SAUDI ARABIA ?-NMN SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 314. SAUDI ARABIA ?-NMN SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 315. SAUDI ARABIA ?-NMN SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 316. SAUDI ARABIA ?-NMN SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 317. SAUDI ARABIA ?-NMN SUPPLEMENTS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 318. SAUDI ARABIA ?-NMN SUPPLEMENTS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 319. SAUDI ARABIA ?-NMN SUPPLEMENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 320. SAUDI ARABIA ?-NMN SUPPLEMENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 321. SAUDI ARABIA ?-NMN SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 322. SAUDI ARABIA ?-NMN SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 323. SAUDI ARABIA ?-NMN SUPPLEMENTS MARKET SIZE, BY DOSAGE RANGE, 2018-2024 (USD MILLION)
TABLE 324. SAUDI ARABIA ?-NMN SUPPLEMENTS MARKET SIZE, BY DOSAGE RANGE, 2025-2030 (USD MILLION)
TABLE 325. SAUDI ARABIA ?-NMN SUPPLEMENTS MARKET SIZE, BY PRICE TIER, 2018-2024 (USD MILLION)
TABLE 326. SAUDI ARABIA ?-NMN SUPPLEMENTS MARKET SIZE, BY PRICE TIER, 2025-2030 (USD MILLION)
TABLE 327. SOUTH AFRICA ?-NMN SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 328. SOUTH AFRICA ?-NMN SUPPLEMENTS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 329. SOUTH AFRICA ?-NMN SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 330. SOUTH AFRICA ?-NMN SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 331. SOUTH AFRICA ?-NMN SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 332. SOUTH AFRICA ?-NMN SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 333. SOUTH AFRICA ?-NMN SUPPLEMENTS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 334. SOUTH AFRICA ?-NMN SUPPLEMENTS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 335. SOUTH AFRICA ?-NMN SUPPLEMENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 336. SOUTH AFRICA ?-NMN SUPPLEMENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 337. SOUTH AFRICA ?-NMN SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 338. SOUTH AFRICA ?-NMN SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 339. SOUTH AFRICA ?-NMN SUPPLEMENTS MARKET SIZE, BY DOSAGE RANGE, 2018-2024 (USD MILLION)
TABLE 340. SOUTH AFRICA ?-NMN SUPPLEMENTS MARKET SIZE, BY DOSAGE RANGE, 2025-2030 (USD MILLION)
TABLE 341. SOUTH AFRICA ?-NMN SUPPLEMENTS MARKET SIZE, BY PRICE TIER, 2018-2024 (USD MILLION)
TABLE 342. SOUTH AFRICA ?-NMN SUPPLEMENTS MARKET SIZE, BY PRICE TIER, 2025-2030 (USD MILLION)
TABLE 343. DENMARK ?-NMN SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 344. DENMARK ?-NMN SUPPLEMENTS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 345. DENMARK ?-NMN SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 346. DENMARK ?-NMN SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 347. DENMARK ?-NMN SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 348. DENMARK ?-NMN SUPPLEMENTS MARKET

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this β-NMN Supplements market report include:
  • ChromaDex Corporation
  • Elysium Health, Inc.
  • ProHealth Longevity, LLC
  • Alive By Nature, Inc.
  • GeneHarbour Group Co., Ltd.
  • Pure Encapsulations, LLC
  • HPN Nutraceuticals, LLC
  • Life Extension Foundation, Inc.
  • Swanson Health Products
  • Zhou Nutrition LLC